Context Although magnetic resonance imaging (MRI) is broadly implemented into active
surveillance (AS) protocols, data on the reliability of serial MRI in order to help guide follow …

Radiomics and genomics represent two of the most promising fields of cancer research,
designed to improve the risk stratification and disease management of patients with prostate …

Localized prostate cancer shows great clinical, genetic and environmental heterogeneity;
however, prostate cancer treatment is currently guided solely by clinical staging, serum PSA …

Simple Summary The increasing interest in implementing artificial intelligence in radiomic
models has occurred alongside advancement in the tools used for computer-aided …

Context Multiparametric magnetic resonance imaging (mpMRI) detects most, but not all,
clinically significant prostate cancer. The genetic basis of prostate cancer visibility and …

Context Studies characterising genomic changes in prostate cancer (PCa) during natural
progression have greatly increased our understanding of the disease. A better …

Since the theory of modern anatomical partitioning of the prostate was proposed, the
differences in the incidence and pathological parameters of prostate cancer between the …

Background We aim to evaluate the impact of multiparametric magnetic resonance imaging
and fusion-target biopsy for early reclassification of patients with low-risk Prostate Cancer in …

Recent developments in multiparametric MRI and MRI‐targeted biopsy have made it
possible to detect clinically significant cancers more accurately and efficiently than ever …

Simple Summary Prostate cancer is one of the leading oncological diseases in the male
population. Early detection and treatment of the disease gives better survival chances and a …